Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy [J Infect Chemother] NLMUID: 9608375"" wg kryterium: JN


Tytuł :
Activity of chlorhexidine acetate in combination with fluconazole against suspensions and biofilms of Candida auris.
Autorzy :
Hao W; Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, China; The Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, 100081, China.
Wang Y; Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, China.
Xi Y; Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, China.
Yang Z; Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, China.
Zhang H; The Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, 100081, China. Electronic address: .
Ge X; Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct 18. Date of Electronic Publication: 2021 Oct 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Delayed diagnosis of human immunodeficiency virus infection in people diagnosed with syphilis: A nationwide cohort study from 2011 to 2018 in Japan.
Autorzy :
Naito T; Department of General Medicine, Juntendo University Faculty of Medicine, Japan. Electronic address: .
Fujibayashi K; Department of General Medicine, Juntendo University Faculty of Medicine, Japan.
Mori H; Department of General Medicine, Juntendo University Faculty of Medicine, Japan.
Fukushima S; Department of General Medicine, Juntendo University Faculty of Medicine, Japan.
Yuda M; Center for Promotion of Data Science, Juntendo University Graduate School of Medicine, Japan.
Fukui N; Center for Promotion of Data Science, Juntendo University Graduate School of Medicine, Japan.
Tsukamoto S; Center for Promotion of Data Science, Juntendo University Graduate School of Medicine, Japan.
Suzuki M; Department of General Medicine, Juntendo University Faculty of Medicine, Japan.
Goto-Hirano K; Department of Cardiovascular Biology and Medicine, Juntendo University Faculty of Medicine, Japan.
Kuwatsuru R; Center for Promotion of Data Science, Juntendo University Graduate School of Medicine, Japan; Department of Radiology, Juntendo University Faculty of Medicine, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Concurrence of imatinib-induced massive pleural/pericardial effusion and Campylobacter bacteremia in an adolescent with chronic myeloid leukemia.
Autorzy :
Su PY; Department of Pediatrics, National Taiwan University Children's Hospital, Taipei, Taiwan.
Tan BF; Department of Pediatrics, National Taiwan University Hsin-Chu Hospital, Hsinchu, Taiwan.
Fu CM; Department of Pediatrics, National Taiwan University Hsin-Chu Hospital, Hsinchu, Taiwan.
Chen CN; Department of Pediatrics, National Taiwan University Hsin-Chu Hospital, Hsinchu, Taiwan.
Chou AK; Department of Pediatrics, National Taiwan University Hsin-Chu Hospital, Hsinchu, Taiwan.
Kung PJ; Department of Pediatrics, National Taiwan University Hsin-Chu Hospital, Hsinchu, Taiwan.
Liao LC; Department of Pharmacy, National Taiwan University Hsin-Chu Hospital, Hsinchu, Taiwan.
Li MJ; Department of Pediatrics, National Taiwan University Hsin-Chu Hospital, Hsinchu, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct 11. Date of Electronic Publication: 2021 Oct 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Risk factors of breakthrough aspergillosis in lung transplant recipients receiving itraconazole prophylaxis.
Autorzy :
Katada Y; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan; Department of Infection Control and Prevention, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Nakagawa S; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Nagao M; Department of Infection Control and Prevention, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan; Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Yoshida Y; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan; Department of Infection Control and Prevention, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Matsuda Y; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Yamamoto Y; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Itohara K; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Imai S; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Yonezawa A; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Nakagawa T; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Matsubara K; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan; Department of Pharmacy, Wakayama Medical University, 811-1 Kimiidera, Wakayama, 641-8509, Japan.
Tanaka S; Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Nakajima D; Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Date H; Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Terada T; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin- Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. Electronic address: .
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct 11. Date of Electronic Publication: 2021 Oct 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Inactivation of human norovirus by chlorous acid water, a novel chlorine-based disinfectant.
Autorzy :
Goda H; Sankei Co. Ltd., 2-2-53 Shiromi, Chuou-ku, Osaka, Japan; Laboratory of Food Hygiene, Faculty of Applied Life Science, Nippon Veterinary and Life Science University, 1-7-1, Kyonancho, Musashino-shi, Tokyo, 180-8602, Japan.
Nakayama-Imaohji H; Department of Microbiology, Faculty of Medicine, Kagawa University, 1750-1, Miki, Kagawa, 761-0793, Japan.
Yamaoka H; Sankei Co. Ltd., 2-2-53 Shiromi, Chuou-ku, Osaka, Japan; Department of Microbiology, Faculty of Medicine, Kagawa University, 1750-1, Miki, Kagawa, 761-0793, Japan.
Tada A; Department of Microbiology, Faculty of Medicine, Kagawa University, 1750-1, Miki, Kagawa, 761-0793, Japan.
Nagao T; Department of Science for Human Health Welfare Care Major, Shikoku University Junior College.
Fujisawa T; Laboratory of Food Hygiene, Faculty of Applied Life Science, Nippon Veterinary and Life Science University, 1-7-1, Kyonancho, Musashino-shi, Tokyo, 180-8602, Japan.
Koyama AH; Department of Microbiology, Faculty of Medicine, Kagawa University, 1750-1, Miki, Kagawa, 761-0793, Japan.
Kuwahara T; Department of Microbiology, Faculty of Medicine, Kagawa University, 1750-1, Miki, Kagawa, 761-0793, Japan. Electronic address: .
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct 09. Date of Electronic Publication: 2021 Oct 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Blood cultures should be collected for acute cholangitis regardless of severity.
Autorzy :
Otani T; Department of Emergency Medicine, Hiroshima City Hiroshima Citizens Hospital, 7-33 Motomachi, Naka-ku, Hiroshima-city, Hiroshima, 730-8518, Japan. Electronic address: .
Ichiba T; Department of Emergency Medicine, Hiroshima City Hiroshima Citizens Hospital, 7-33 Motomachi, Naka-ku, Hiroshima-city, Hiroshima, 730-8518, Japan.
Seo K; Department of Emergency Medicine, Hiroshima City Hiroshima Citizens Hospital, 7-33 Motomachi, Naka-ku, Hiroshima-city, Hiroshima, 730-8518, Japan.
Naito H; Department of Emergency Medicine, Hiroshima City Hiroshima Citizens Hospital, 7-33 Motomachi, Naka-ku, Hiroshima-city, Hiroshima, 730-8518, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct 08. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Facilitating the deployment of Japanese human resources for responding global outbreaks of emerging and Re-emerging infectious diseases: A cross-sectional study.
Autorzy :
Nomoto H; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-cho, Aoba-ku, Sendai, Miyagi, Japan; WHO Collaborating Centre for Prevention, Preparedness and Response to Emerging Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, Japan.
Ishikane M; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, Japan; WHO Collaborating Centre for Prevention, Preparedness and Response to Emerging Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, Japan; AMR Clinical Reference Center, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, Japan. Electronic address: .
Lee S; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, Japan; WHO Collaborating Centre for Prevention, Preparedness and Response to Emerging Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, Japan; Department of Epidemiology and Clinical Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, 3-1-24, Matsuyama Kiyose, Tokyo, Japan.
Komiya N; Department of Infectious Diseases, Japanese Red Cross Wakayama Medical Center, 4-20, Komatsubaradori, Wakayama City, Wakayama, Japan.
Maeki T; Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, 162-8640, Japan.
Matsui T; Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku, Tokyo, Japan.
Morita K; Department of Virology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki City, Nagasaki, Japan.
Oshitani H; Department of Virology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Saijo M; Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, 162-8640, Japan.
Yamagishi T; Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku, Tokyo, Japan.
Yamamoto T; Department of International Health and Medical Anthropology, Institute of Tropical Medicine, Nagasaki University, 1-12-4, Sakamoto, Nagasaki City, Nagasaki, Japan.
Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-cho, Aoba-ku, Sendai, Miyagi, Japan; WHO Collaborating Centre for Prevention, Preparedness and Response to Emerging Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, Japan; AMR Clinical Reference Center, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct 08. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prognostic factors in patients hospitalized with community-acquired aspiration pneumonia.
Autorzy :
Seo H; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Cha SI; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. Electronic address: .
Lee WK; Biostatistics, Medical Research Collaboration Center, Kyungpook National University, Daegu, Republic of Korea.
Park JE; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Choi SH; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Lee YH; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Yoo SS; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Lee SY; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Lee J; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Kim CH; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Park JY; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct 06. Date of Electronic Publication: 2021 Oct 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Epidemiological impact of universal varicella vaccination on consecutive emergency department visits for varicella and its economic impact among children in Kobe City, Japan.
Autorzy :
Yamaguchi H; Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan. Electronic address: .
Nozu K; Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan.
Ishiko S; Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan.
Nagase H; Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan.
Ninchoji T; Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan.
Nagano C; Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan.
Takeda H; Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan.
Unzaki A; Kobe Children's Primary Emergency Medical Center, 1-4-1 Wakihamakaigandori, Chuo-ku, Kobe, Hyogo 651-0073, Japan.
Ishibashi K; Kobe Children's Primary Emergency Medical Center, 1-4-1 Wakihamakaigandori, Chuo-ku, Kobe, Hyogo 651-0073, Japan.
Morioka I; Department of Pediatrics and Child Health, Nihon University School of Medicine, 30-1, Oyaguchi, Kami-cho, Itabashi-ku, Tokyo 173-8610, Japan.
Iijima K; Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan.
Ishida A; Kobe Children's Primary Emergency Medical Center, 1-4-1 Wakihamakaigandori, Chuo-ku, Kobe, Hyogo 651-0073, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct 04. Date of Electronic Publication: 2021 Oct 04.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Evaluation of minocycline combined with favipiravir therapy in coronavirus disease 2019 patients: A case-series study.
Autorzy :
Itoh K; Department of Infectious Diseases, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; Department of Internal Medicine, National Hospital Organization Awara Hospital, Awara, Japan. Electronic address: .
Sakamaki I; Department of Infectious Diseases, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; Division of Infection and Clinical Immunology, University of Fukui Hospital, Fukui, Japan.
Hirota T; Department of Infectious Diseases, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; Division of Infection and Clinical Immunology, University of Fukui Hospital, Fukui, Japan.
Iwasaki H; Division of Infection and Clinical Immunology, University of Fukui Hospital, Fukui, Japan; Division of Infection Control and Prevention, University of Fukui Hospital, Fukui, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct 02. Date of Electronic Publication: 2021 Oct 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Multisystem inflammatory syndrome in adults after acute coronavirus disease 2019 in a Japanese woman: A case report.
Autorzy :
Miyamoto K; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan; Department of Infection Prevention and Control, Wakayama Medical University, Wakayama City, Wakayama, Japan. Electronic address: .
Koizumi Y; Department of Infection Prevention and Control, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Tamura S; Department of Infection Prevention and Control, Wakayama Medical University, Wakayama City, Wakayama, Japan; Department of Hematology/Oncology, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Nakashima T; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Kobai K; Department of Anesthesiology, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Tanaka R; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Shibata M; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Shima N; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Nemoto S; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Fukumoto N; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Kato S; Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct 02. Date of Electronic Publication: 2021 Oct 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Determination of reactivation rate and risk factors for Hepatitis B virus reactivation in low-positive cases: A retrospective cohort study.
Autorzy :
Yonezawa H; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan.
Tanaka S; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan; Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan. Electronic address: .
Furuya M; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan.
Yamada K; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan.
Asanuma K; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan.
Fujiya Y; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Miyanishi K; Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Takahashi S; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Kato J; Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct; Vol. 27 (10), pp. 1454-1458. Date of Electronic Publication: 2021 Jun 24.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B*/epidemiology
Hepatitis B virus*/genetics
DNA, Viral/genetics ; Hepatitis B Surface Antigens ; Humans ; Retrospective Studies ; Risk Factors ; Virus Activation
Czasopismo naukowe
Tytuł :
Infection with capsular genotype K1-ST23 hypervirulent Klebsiella pneumoniae isolates in Japan after a stay in East Asia: Two cases and a literature review.
Autorzy :
Nakamura K; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
Nomoto H; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan; Emerging and Reemerging Infectious Diseases, National Center for Global Health and Medicine, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-cho, Aoba-ku, Sendai City, Miyagi, 980-8575, Japan.
Harada S; Department of Infection Control and Prevention, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Suzuki M; Department of Microbiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Yomono K; Teikyo University Chiba Medical Center, 3426-3 Anesaki, Ichihara City, Chiba, 299-0111, Japan.
Yokochi R; Teikyo University Chiba Medical Center, 3426-3 Anesaki, Ichihara City, Chiba, 299-0111, Japan.
Hagino N; Teikyo University Chiba Medical Center, 3426-3 Anesaki, Ichihara City, Chiba, 299-0111, Japan.
Nakamoto T; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
Moriyama Y; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
Yamamoto K; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
Kutsuna S; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan. Electronic address: .
Ohmagari N; Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan; Emerging and Reemerging Infectious Diseases, National Center for Global Health and Medicine, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-cho, Aoba-ku, Sendai City, Miyagi, 980-8575, Japan; AMR Clinical Reference Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct; Vol. 27 (10), pp. 1508-1512. Date of Electronic Publication: 2021 Jun 02.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Klebsiella Infections*/drug therapy
Klebsiella pneumoniae*/genetics
Adult ; China ; Far East ; Genotype ; Humans ; Japan ; Male ; Middle Aged ; Virulence
Czasopismo naukowe
Tytuł :
Discrepancy of SARS-CoV-2 PCR results due to the sample collection sites and possible improper sampling.
Autorzy :
Irifune S; Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Ashizawa N; Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. Electronic address: .
Takazono T; Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Mutantu P; Department of Virology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan; Department of Molecular Virology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
Nabeshima T; Department of Virology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
Ngwe Tun MM; Department of Virology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
Ota K; Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Hirayama T; Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Fujita A; Infection Control and Education Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852- 8501, Japan.
Tashiro M; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan; Infection Control and Education Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852- 8501, Japan.
Tanaka T; Infection Control and Education Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852- 8501, Japan.
Yamamoto K; Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan; Infection Control and Education Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852- 8501, Japan.
Imamura Y; Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Miyazaki T; Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Sawai T; Department of Respiratory Medicine, Nagasaki Harbor Medical Center, 6-39 Shinchimachi, Nagasaki, 850-8555, Japan.
Izumikawa K; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan; Infection Control and Education Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852- 8501, Japan.
Yanagihara K; Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Morita K; Department of Virology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan; Department of Molecular Virology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
Mukae H; Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct; Vol. 27 (10), pp. 1525-1528. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
COVID-19*
SARS-CoV-2*
Aged ; Female ; Humans ; Nasopharynx ; Polymerase Chain Reaction ; RNA, Viral ; Specimen Handling
Czasopismo naukowe
Tytuł :
Improvement in the appropriate antimicrobial usage for treating pediatric acute otitis media in Japan: A descriptive study using nation-wide electronic medical record data.
Autorzy :
Kono M; Department of Otorhinolaryngology-Head and Neck Surgery, Wakayama Medical University, 811-1 Kimiidera, Wakayama-shi, Wakayama, Wakayama, 641-8510, Japan.
Sugita G; Department of Otorhinolaryngology-Head and Neck Surgery, Wakayama Medical University, 811-1 Kimiidera, Wakayama-shi, Wakayama, Wakayama, 641-8510, Japan.
Itahashi K; Medical Affairs Department, Meiji Seika Pharma Co., Ltd., 2-4-16 Kyobashi Chuo-ku, Tokyo, 104-8002, Japan.
Sasagawa Y; Regulatory Affairs & Clinical Data Science Department, Meiji Seika Pharma Co., Ltd., 2-4-16 Kyobashi Chuo-ku, Tokyo, 104-8002, Japan.
Iwama Y; Regulatory Affairs & Clinical Data Science Department, Meiji Seika Pharma Co., Ltd., 2-4-16 Kyobashi Chuo-ku, Tokyo, 104-8002, Japan.
Hiraoka S; Medical Affairs Department, Meiji Seika Pharma Co., Ltd., 2-4-16 Kyobashi Chuo-ku, Tokyo, 104-8002, Japan.
Ohtani M; Department of Otorhinolaryngology-Head and Neck Surgery, Wakayama Medical University, 811-1 Kimiidera, Wakayama-shi, Wakayama, Wakayama, 641-8510, Japan.
Hotomi M; Department of Otorhinolaryngology-Head and Neck Surgery, Wakayama Medical University, 811-1 Kimiidera, Wakayama-shi, Wakayama, Wakayama, 641-8510, Japan. Electronic address: .
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct; Vol. 27 (10), pp. 1413-1422. Date of Electronic Publication: 2021 Jun 26.
Typ publikacji :
Journal Article
MeSH Terms :
Electronic Health Records*
Otitis Media*/drug therapy
Otitis Media*/epidemiology
Acute Disease ; Anti-Bacterial Agents/therapeutic use ; Child ; Child, Preschool ; Humans ; Infant ; Japan/epidemiology ; Pneumococcal Vaccines
Czasopismo naukowe
Tytuł :
Efficacy of early administration of liposomal amphotericin B in patients with septic shock: A nationwide observational study.
Autorzy :
Tashiro M; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan; Nagasaki University Infection Control and Education Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. Electronic address: .
Takazono T; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan; Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. Electronic address: .
Ota Y; Department of Nephrology, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. Electronic address: .
Wakamura T; Medical Affairs Division, Sumitomo Dainippon Pharma Co., Ltd, 1-13-1 Kyobashi, Chuo-ku, Tokyo, 104-8356, Japan. Electronic address: .
Takahashi A; Deloitte Tohmatsu Consulting LLC, Marunouchi Nijubashi Building, 3-2-3 Marunouchi, Chiyoda-ku, Tokyo, 100-8361, Japan. Electronic address: .
Sato K; Deloitte Tohmatsu Consulting LLC, Marunouchi Nijubashi Building, 3-2-3 Marunouchi, Chiyoda-ku, Tokyo, 100-8361, Japan. Electronic address: .
Miyazaki T; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan; Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. Electronic address: .
Obata Y; Department of Nephrology, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. Electronic address: .
Nishino T; Department of Nephrology, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. Electronic address: .
Izumikawa K; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan; Nagasaki University Infection Control and Education Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. Electronic address: .
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct; Vol. 27 (10), pp. 1471-1476. Date of Electronic Publication: 2021 Jun 26.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Shock, Septic*/drug therapy
Amphotericin B/therapeutic use ; Antifungal Agents/therapeutic use ; Humans
Czasopismo naukowe
Tytuł :
Disseminated Mycobacterium abscessus subspecies massiliense infection and subsequent prosthetic joint infection in a hemodialysis patient: A case report.
Autorzy :
Tsuruyama Y; Department of General Internal Medicine and Infectious Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8902, Japan.
Mori N; Department of General Internal Medicine and Infectious Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8902, Japan. Electronic address: .
Fujisawa T; Department of Emergency Medicine, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8902, Japan.
Katayama M; Department of General Internal Medicine and Infectious Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8902, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct; Vol. 27 (10), pp. 1504-1507. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Mycobacterium Infections, Nontuberculous*/drug therapy
Mycobacterium abscessus*
Aged ; Anti-Bacterial Agents/therapeutic use ; Azithromycin/therapeutic use ; Humans ; Male ; Renal Dialysis/adverse effects
Czasopismo naukowe
Tytuł :
Retrospective study of the efficacy and safety of metronidazole and vancomycin for Clostridioides difficile infection.
Autorzy :
Misawa K; Division of Pharmacodynamics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan.
Iketani O; Department of Infectious Diseases, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Enoki Y; Division of Pharmacodynamics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan. Electronic address: .
Taguchi K; Division of Pharmacodynamics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan.
Uno S; Department of Infectious Diseases, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Uwamino Y; Department of Infectious Diseases, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Hasegawa N; Department of Infectious Diseases, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Matsumoto K; Division of Pharmacodynamics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct; Vol. 27 (10), pp. 1407-1412. Date of Electronic Publication: 2021 May 20.
Typ publikacji :
Journal Article
MeSH Terms :
Clostridioides difficile*
Clostridium Infections*/drug therapy
Clostridium Infections*/epidemiology
Aged ; Anti-Bacterial Agents/adverse effects ; Clostridioides ; Female ; Humans ; Metronidazole/adverse effects ; Retrospective Studies ; Vancomycin/adverse effects
Czasopismo naukowe
Tytuł :
The evaluation of a novel digital immunochromatographic assay with silver amplification to detect SARS-CoV-2.
Autorzy :
Kurihara Y; Division of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki, 305-8558, Japan; Department of Infectious Diseases, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.
Kiyasu Y; Division of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki, 305-8558, Japan; Department of Infectious Diseases, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan. Electronic address: .
Akashi Y; Department of Infectious Diseases, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan; Akashi Internal Medicine Clinic, 3-1-63 Asahigaoka, Kashiwara, Osaka, 582-0026, Japan.
Takeuchi Y; Division of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki, 305-8558, Japan; Department of Infectious Diseases, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.
Narahara K; Mizuho Medy Co., Ltd., 5-4 Fujinoki-machi, Tosu City, Saga, 841-0048, Japan.
Mori S; Mizuho Medy Co., Ltd., 5-4 Fujinoki-machi, Tosu City, Saga, 841-0048, Japan.
Takeshige T; Mizuho Medy Co., Ltd., 5-4 Fujinoki-machi, Tosu City, Saga, 841-0048, Japan.
Notake S; Department of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki, 305-8558, Japan.
Ueda A; Department of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki, 305-8558, Japan.
Nakamura K; Department of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki, 305-8558, Japan.
Ishikawa H; Department of Respiratory Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki, 305-8558, Japan.
Suzuki H; Department of Infectious Diseases, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan; Department of Infectious Diseases, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct; Vol. 27 (10), pp. 1493-1497. Date of Electronic Publication: 2021 Jul 13.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
COVID-19*
SARS-CoV-2*
Antigens, Viral ; Humans ; Immunoassay ; Sensitivity and Specificity ; Silver
Czasopismo naukowe
Tytuł :
Usefulness of β-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study.
Autorzy :
Ito A; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan. Electronic address: .
Ishida T; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan. Electronic address: .
Tachibana H; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan; Department of Respiratory Medicine, National Hospital Organization Minami Kyoto Hospital, 11 Nakaashihara, Joyo, Kyoto 610-0113, Japan. Electronic address: .
Nakanishi Y; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan. Electronic address: .
Tokioka F; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan. Electronic address: .
Yamazaki A; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan; Department of Respiratory Medicine, Shiga University of Medical Science, Tsukinowa Seta-cho, Otsu, Shiga 520-2192, Japan. Electronic address: .
Washio Y; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Higashiku, Maidashi, Fukuoka 812-8582, Japan. Electronic address: .
Irie H; Department of Anesthesia, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan. Electronic address: .
Otake T; Department of Intensive Care, Ohara Healthcare Foundation, Kurashiki Central Hospital, Kurashiki, Okayama 710-8602, Japan. Electronic address: .
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct; Vol. 27 (10), pp. 1447-1453. Date of Electronic Publication: 2021 Jun 17.
Typ publikacji :
Journal Article
MeSH Terms :
Community-Acquired Infections*/drug therapy
Pneumonia, Bacterial*/drug therapy
Anti-Bacterial Agents/therapeutic use ; Cohort Studies ; Drug Therapy, Combination ; Humans ; Intensive Care Units ; Macrolides/therapeutic use ; Propensity Score ; Prospective Studies ; Treatment Outcome ; beta-Lactams/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies